pone.0295897.s006.pdf (91.67 kB)
Trends in teratogenic drug exposure during pregnancy between 2013 and 2019.
journal contribution
posted on 2024-01-10, 18:23 authored by Margaux Louchet, Mathis Collier, Nathanaël Beeker, Laurent Mandelbrot, Jeanne Sibiude, Laurent Chouchana, Jean Marc TreluyerNumber of pregnancies (rate per 10,000 pregnancies).
(PDF)
History
Usage metrics
Categories
Keywords
92 per 1044 per 10389 per 10299 per 1013 per 10128 per 10122 per 10xlink "> describeteratogenic drugs decreasedfetotoxic drugs decreasedthird trimester remainsxlink "> prevalence000 pregnancies ).harmful drug exposurexlink ">teratogenic drugsharmful drugfetotoxic drugsthird trimesterharmful drugsthird trimestersinflammatory drugsfirst trimesterthree trimestersstudy periodsteroidal antirecent yearspreconceptional periodoutcomes correspondingnsaids ),nsaid exposurenationwide studymedical terminationslive birthsdefined usingdefined accordingcritical periodscritical period90 days284 pregnancies25 pregnancies000 pregnancies
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC